Nagarathinam Kumar, Jaenecke Frank, Nakada-Nakura Yoshiko, Hotta Yunhon, Liu Kehong, Iwata So, Stubbs Milton T, Nomura Norimichi, Tanabe Mikio
ZIK HALOmem, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes Strasse 3, 06120 Halle (Saale), Germany.
Department of Cell Biology, Graduate School of Medicine, Kyoto University, Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Acta Crystallogr F Struct Biol Commun. 2017 Jul 1;73(Pt 7):423-430. doi: 10.1107/S2053230X17008500. Epub 2017 Jun 20.
The active efflux of antibiotics by multidrug-resistance (MDR) transporters is a major pathway of drug resistance and complicates the clinical treatment of bacterial infections. MdfA is a member of the major facilitator superfamily (MFS) from Escherichia coli and provides resistance to a wide variety of dissimilar toxic compounds, including neutral, cationic and zwitterionic substances. The 12-transmembrane-helix MdfA was expressed as a GFP-octahistidine fusion protein with a TEV protease cleavage site. Following tag removal, MdfA was purified using two chromatographic steps, complexed with a Fab fragment and further purified using size-exclusion chromatography. MdfA and MdfA-Fab complexes were subjected to both vapour-diffusion and lipidic cubic phase (LCP) crystallization techniques. Vapour-diffusion-grown crystals were of type II, with poor diffraction behaviour and weak crystal contacts. LCP lipid screening resulted in type I crystals that diffracted to 3.4 Å resolution and belonged to the hexagonal space group P622.
多药耐药(MDR)转运蛋白对抗生素的主动外排是耐药的主要途径,使细菌感染的临床治疗变得复杂。MdfA是来自大肠杆菌的主要易化子超家族(MFS)的成员,对多种不同的有毒化合物具有抗性,包括中性、阳离子和两性离子物质。具有12个跨膜螺旋的MdfA被表达为带有TEV蛋白酶切割位点的GFP-八组氨酸融合蛋白。去除标签后,通过两步色谱法纯化MdfA,与Fab片段复合,并通过尺寸排阻色谱法进一步纯化。对MdfA和MdfA-Fab复合物进行了气相扩散和脂质立方相(LCP)结晶技术。气相扩散生长的晶体为II型,衍射行为较差且晶体接触较弱。LCP脂质筛选得到了I型晶体,其衍射分辨率为3.4 Å,属于六方空间群P622。